Company intelligence / Profile preview

Nilogen Oncosystems

Tampa, Florida, United Statesnilogen.com ↗

Ownership: Private
Employees: ~16
Development stage: Commercial

Overview

Nilogen Oncosystems offers advanced ex vivo human tumor modeling platforms that retain the full heterogeneity and immune microenvironment of patient tumors. Their patented tumoroid technology enables more predictive preclinical testing of immuno-oncology drugs by closely mirroring clinical responses. The company’s services support pharmaceutical partners in optimizing candidate selection and increasing the likelihood of clinical trial success. No direct therapeutic programs or clinical results are reported as they are a service/platform provider rather than a product developer.

Therapeutic areas: Oncology
Modalities: Ex vivo human tumor tissue assays (tumoroids)Immuno-oncology models
Industry: Drug Discovery Services

Partnerships

Not specifically disclosed; clients include pharmaceutical/biotech companies developing oncology drugs.

Beyond the preview

Go deeper on Nilogen Oncosystems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nilogen Oncosystems.

Explore the full profile